Company Filing History:
2 out of 7 
1 out of 5,313 
1 out of 5 Years Active: 2010-2019
Title: Thomas Wight: Innovator in Immune Modulation and Disease Treatment
Introduction
Thomas Wight is a notable inventor based in Seattle, WA (US). He has made significant contributions to the field of immune modulation and treatment of various diseases. With a total of 4 patents, his work focuses on innovative methods and compositions that address autoimmune and inflammatory conditions.
Latest Patents
Wight's latest patents include a treatment involving 4-methylumbelliferone for immune modulation. This invention describes compositions for treating autoimmune, allergic, or atopic diseases that comprise a compound inhibiting hyaluronan synthesis along with a pharmaceutically acceptable carrier. The patent outlines methods for treating conditions such as autoimmune diabetes and multiple sclerosis by administering a composition that effectively inhibits hyaluronan synthesis in mammalian subjects. Another significant patent involves the inhibition of versican with siRNA and other molecules, providing methods for treating various diseases, including fibrotic lung disease, restenosis, atherosclerosis, cancer, and inflammatory diseases.
Career Highlights
Throughout his career, Thomas Wight has worked at the Benaroya Research Institute at Virginia Mason, where he has contributed to groundbreaking research in his field. His innovative approaches have led to advancements in understanding and treating complex diseases.
Collaborations
Wight has collaborated with notable individuals in his field, including Mervyn John Merrilees and Mervyn Merrilees. These collaborations have further enriched his research and development efforts.
Conclusion
Thomas Wight's contributions to immune modulation and disease treatment through his patents highlight his role as an influential inventor. His work continues to pave the way for innovative solutions in healthcare.